Dr. Howard will present this study in an oral presentation on Sunday, December 11, at 5:00 p.m. PST at the Manchester Grand Hyatt in the Elizabeth Ballroom AB.
American Society of Hematology 53rd Annual Meeting
The study authors and press program moderator will be available for interviews after the press conference or by telephone. Additional press briefings will take place throughout the meeting on new treatment techniques for patients with bleeding and clotting disorders, targeted therapies for acute and chronic leukemia, improving recovery and outcomes in transplantation, and emerging treatments for lymphoma and myeloma. For the complete annual meeting program and abstracts, visit www.hematology.org/2011abstracts. Get up-to-date information about the annual meeting by following ASH on Twitter @ASH_hematology.
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
 Sickle Cell Disease: Data & Statistics. http://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed October 18, 2011
|SOURCE American Society of Hematology|
Copyright©2010 PR Newswire.
All rights reserved